ClinicalTrials.gg
CompletedNCT07681934Updated Nov 13, 2026

Swaddling and Breast Milk Odor for Stress and Comfort in Late Preterm Babies Receiving High-Flow Breathing Support Through the Nose

An interventional study of Maternal Breast Milk Odor and Safe Swaddling in Prematurity, sponsored by KTO Karatay University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 34 Weeks to 36 Weeks. Per ClinicalTrials.gov, last updated 2026-11-13.

Sponsored by KTO Karatay University · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Registered 1 year 1 month after the study started (first participant enrolled Jun 2024, registered Aug 2025).
Updated Nov 13, 2026Now CompletedPrimary completion moved+4 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
72
Allocation
Randomized
Ages
34 Weeks to 36 Weeks
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 247 studies in Premature Birth with a site in Turkey — 44 open to participants now, 49 under way, none of them phase 3. Premature Birth · Turkey.

Enrollment
77th of 197
72 · median 64
Started
2024
with 33 others
No phase
192 of 247
39 open now
Registered
205th of 247
by date

Among the 247 studies in Premature Birth with a site in Turkey, this one is the 77th largest by enrollment of the 197 interventional ones that give a count, is one of 34 that started in 2024, is one of 192 with no phase, and was the 205th registered.

Premature Birth

2,557 studies on the registry are indexed under Premature Birth; 504 are open to participants now.

Browse Premature Birth studies →

Open to participants now

44 of the 247 studies in Premature Birth with a site in Turkey are open now. Recruiting first, the newest first:

39 more — sign in →

All 44 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 318 Premature Birth studies recruiting now, 88 (28%) set no upper age limit and 226 (71%) stop at 75 or younger; 243 take children under 18; 104 take healthy volunteers.

This study: 34 Weeks to 36 Weeks · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 247 studies in Premature Birth with a site in Turkey, or all of them as a file.
02

Study summary

This study compared two approaches to reducing stress and improving comfort in babies born between 34 and 36 completed weeks of pregnancy who were receiving high-flow breathing support through small tubes in the nose.

Seventy-two babies were assigned by chance to one of three groups, with 24 babies in each group. One group was gently swaddled for 20 minutes. A second group was exposed for 20 minutes to the smell of freshly expressed milk from each baby's own mother. The third group received the neonatal intensive care unit's usual care and was observed for 20 minutes.

The study team assessed stress and comfort and recorded heart rate, breathing rate, blood oxygen level, and body temperature at the start of the observation period and again at 5 and 20 minutes. The purpose was to compare how these measures changed over time across the three groups.

03

Conditions studied

  • Prematurity

Browse trials for

Keywords

  • Late Preterm Infants
  • High-Flow Nasal Cannula
  • Safe Swaddling
  • Maternal Breast Milk Odor
  • Neonatal Stress
  • Neonatal Comfort
04

Who can participate

The criteria were revised on the registry on Nov 13, 2026. See what changed

Ages eligible
34 Weeks to 36 Weeks
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Gestational age at birth of 34 weeks 0 days to 36 weeks 6 days, inclusive.
  • Within the first 28 days of life at enrollment.
  • Receiving noninvasive respiratory support via a high-flow nasal cannula (HFNC).
  • Birth weight of at least 1,500 g.
  • The infant's mother was able to provide expressed breast milk.
  • No clinical condition that precluded safe positioning or swaddling.
  • Written obtained from a parent.

Exclusion criteria

Exclusion Criteria:

  • A painful procedure within 1 hour before the start of the planned study session.
  • Receipt of a medication with analgesic or sedative effects within 6 hours before the start of the planned study session.
  • Previous surgery.
  • An active or treatment-requiring clinical condition that could affect physiological measurements or the stress response, such as hypoglycemia, hyperbilirubinemia, or acute infection.
  • Cerebral hypoxia or ischemia.
  • Intraventricular hemorrhage.
  • A major congenital anomaly.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
72 participants (actual)

Study arms

  • Experimental
    Maternal Breast Milk Odor

    Infants were exposed for 20 minutes to the odor of freshly expressed breast milk from their own mothers. Ten drops of milk were applied to sterile gauze placed in a sterile container. The container was positioned inside the incubator approximately 1-2 cm from the infant's nose and remained in place throughout the exposure period.

    Other: Maternal Breast Milk Odor

  • Experimental
    Safe Swaddling

    Infants were positioned supine and swaddled for 20 minutes using a thin, breathable muslin cloth measuring 90 × 90 cm. The upper limbs were held alongside the trunk in slight flexion. The lower limbs were left free to allow hip flexion and abduction. The cloth was secured loosely enough to permit chest expansion and spontaneous movement.

    Other: Safe Swaddling

  • No intervention
    Standard Care

    Infants received the neonatal intensive care unit's standard care during a 20-minute observation period. No additional study intervention was administered.

Interventions

  • OtherMaternal Breast Milk Odor

    Ten drops of freshly expressed breast milk from each infant's own mother were applied to sterile gauze in a sterile container. The container was placed inside the incubator near the infant's nose for 20 minutes.

  • OtherSafe Swaddling

    Infants were swaddled in the supine position for 20 minutes using a thin, breathable muslin cloth measuring 90 × 90 cm. The cloth was secured loosely to allow chest expansion and spontaneous movement, and the lower limbs were left free to permit hip flexion and abduction.

06

What researchers measure

Primary outcomes

  1. Change in Newborn Stress Scale Total Score Over Time

    Stress was assessed using the Newborn Stress Scale. The scale comprises eight observational domains, each scored from 0 to 2. Total scores range from 0 to 16, with higher scores indicating greater stress. Changes in total scores across the three assessment time points were compared among the study groups.

    Time frame: At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.

Secondary outcomes

  1. Premature Infant Comfort Scale Total Score

    Comfort was assessed using the Turkish version of the Premature Infant Comfort Scale. Seven indicators are each scored from 1 to 5. Total scores range from 7 to 35, with lower scores indicating greater comfort.

    Time frame: At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.

  2. Heart Rate

    Heart rate was read directly from the bedside monitor and recorded in beats per minute.

    Time frame: At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.

  3. Respiratory Rate

    Respiratory rate was read directly from the bedside monitor and recorded in breaths per minute.

    Time frame: At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.

  4. Peripheral Oxygen Saturation (SpO₂)

    Peripheral oxygen saturation was read directly from the bedside monitor and recorded as a percentage.

    Time frame: At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.

  5. Body Temperature

    Body temperature was read directly from the bedside monitor and recorded in degrees Celsius (°C).

    Time frame: At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No — Security

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jun 2024 to primary completion in Apr 2026, 22 months.

Of 746 non-industry interventional studies with no phase under Premature Birth, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 47. This study's 22 months is close to that.

Counting every sponsor, half of 764 studies reached it within 24 months; a quarter within 12 and three quarters within 47.

Primary completion moved once since we started tracking on Sep 25, 2026: Aug 2025 → Apr 2026, on Nov 13, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Aug 19, 2025
First posted
Jul 2, 2026
StartActual
Jun 28, 2024
Primary completionActual
Apr 30, 2026was Aug 2025
CompletionActual
Aug 30, 2026
Last update
Nov 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Active, not recruiting→Completed
changed Nov 13, 2026
Primary completion
Aug 30, 2025→Apr 30, 2026
Nov 13, 2026
Eligibility
1 inclusion criterion edited, 6 added, 5 removed; 2 exclusion criteria edited, 5 added, 5 removed
What changed in the criteria
Inclusion criteria
  • RemovedNewborns with gestational weeks between 340/7-366/7,
  • AddedGestational age at birth of 34 weeks 0 days to 36 weeks 6 days, inclusive.
  • EditedInWithin the first 28 days of life, at enrollment.
  • RemovedHigh-flow nasal cannula applied,
  • RemovedBirth weight 1500 gr and above,
  • RemovedBreastfeeding mothers,
  • RemovedNo health problems that would prevent positioning,
  • AddedReceiving noninvasive respiratory support via a high-flow nasal cannula (HFNC).
  • AddedBirth weight of at least 1,500 g.
  • AddedThe infant's mother was able to provide expressed breast milk.
  • AddedNo clinical condition that precluded safe positioning or swaddling.
  • AddedWritten informed consent obtained from a parent.
Exclusion criteria
  • RemovedThose who have had a painful procedure within the last hour,
  • RemovedThose who have taken analgesic/sedative drugs within the last 6 hours,
  • RemovedThose who have undergone any surgical intervention,
  • RemovedThose with other diagnoses (hyperbilirubinemia, hypoglycemia, etc.),
  • AddedA painful procedure within 1 hour before the start of the planned study session.
  • AddedReceipt of a medication with analgesic or sedative effects within 6 hours before the start of the planned study session.
  • AddedPrevious surgery.
  • AddedAn active or treatment-requiring clinical condition that could affect physiological measurements or the stress response, such as hypoglycemia, hyperbilirubinemia, or acute infection.
  • EditedThose with cerebralCerebral hypoxia/ or ischemia,.
  • EditedThose with intraventricularIntraventricular hemorrhage,.
  • RemovedNewborns with congenital anomalies
  • AddedA major congenital anomaly.
Nov 13, 2026
Interventions
Added Maternal Breast Milk Odor·Safe Swaddling; removed Breast Milk Smell·Arson·Control. Arms added: Maternal Breast Milk Odor·Safe Swaddling·Standard Care; arms removed: Breast Milk Smell Group·Arson Group·Control Group
Nov 13, 2026
Primary outcomes
1 edited
What changed in the outcomes
  • ChangedBefore Premature Baby Comfort ScaleNow Change in Newborn Stress Scale Total Score Over TimeTime frame: 9 Months → At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.
Nov 13, 2026
Secondary outcomes
5 added, 1 removed
What changed in the outcomes
  • AddedPremature Infant Comfort Scale Total ScoreTime frame: At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.
  • AddedHeart RateTime frame: At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.
  • AddedRespiratory RateTime frame: At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.
  • AddedPeripheral Oxygen Saturation (SpO₂)Time frame: At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.
  • AddedBody TemperatureTime frame: At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.
  • RemovedNewborn Stress ScaleTime frame: 9 Months
Nov 13, 2026
Title
The Effect of Breast Milk Odor and Swaddling on Physiological Parameters and Stress Levels in Premature Infants Receiving Ventilator Support→Swaddling and Breast Milk Odor for Stress and Comfort in Late Preterm Babies Receiving High-Flow Breathing Support Through the Nose
Nov 13, 2026
Show all 1 update
  1. Nov 13, 2026
    Active, not recruiting→Completed
    Primary completion Aug 30, 2025→Apr 30, 2026
    Eligibility 1 inclusion criterion edited, 6 added, 5 removed; 2 exclusion criteria edited, 5 added, 5 removed
    What changed in the criteria
    Inclusion criteria
    • RemovedNewborns with gestational weeks between 340/7-366/7,
    • AddedGestational age at birth of 34 weeks 0 days to 36 weeks 6 days, inclusive.
    • EditedInWithin the first 28 days of life, at enrollment.
    • RemovedHigh-flow nasal cannula applied,
    • RemovedBirth weight 1500 gr and above,
    • RemovedBreastfeeding mothers,
    • RemovedNo health problems that would prevent positioning,
    • AddedReceiving noninvasive respiratory support via a high-flow nasal cannula (HFNC).
    • AddedBirth weight of at least 1,500 g.
    • AddedThe infant's mother was able to provide expressed breast milk.
    • AddedNo clinical condition that precluded safe positioning or swaddling.
    • AddedWritten informed consent obtained from a parent.
    Exclusion criteria
    • RemovedThose who have had a painful procedure within the last hour,
    • RemovedThose who have taken analgesic/sedative drugs within the last 6 hours,
    • RemovedThose who have undergone any surgical intervention,
    • RemovedThose with other diagnoses (hyperbilirubinemia, hypoglycemia, etc.),
    • AddedA painful procedure within 1 hour before the start of the planned study session.
    • AddedReceipt of a medication with analgesic or sedative effects within 6 hours before the start of the planned study session.
    • AddedPrevious surgery.
    • AddedAn active or treatment-requiring clinical condition that could affect physiological measurements or the stress response, such as hypoglycemia, hyperbilirubinemia, or acute infection.
    • EditedThose with cerebralCerebral hypoxia/ or ischemia,.
    • EditedThose with intraventricularIntraventricular hemorrhage,.
    • RemovedNewborns with congenital anomalies
    • AddedA major congenital anomaly.
    Primary outcomes 1 edited
    What changed in the outcomes
    • ChangedBefore Premature Baby Comfort ScaleNow Change in Newborn Stress Scale Total Score Over TimeTime frame: 9 Months → At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.
    Secondary outcomes 5 added, 1 removed
    What changed in the outcomes
    • AddedPremature Infant Comfort Scale Total ScoreTime frame: At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.
    • AddedHeart RateTime frame: At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.
    • AddedRespiratory RateTime frame: At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.
    • AddedPeripheral Oxygen Saturation (SpO₂)Time frame: At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.
    • AddedBody TemperatureTime frame: At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.
    • RemovedNewborn Stress ScaleTime frame: 9 Months
    Interventions Added Maternal Breast Milk Odor·Safe Swaddling; removed Breast Milk Smell·Arson·Control. Arms added: Maternal Breast Milk Odor·Safe Swaddling·Standard Care; arms removed: Breast Milk Smell Group·Arson Group·Control Group
    Title The Effect of Breast Milk Odor and Swaddling on Physiological Parameters and Stress Levels in Premature Infants Receiving Ventilator Support→Swaddling and Breast Milk Odor for Stress and Comfort in Late Preterm Babies Receiving High-Flow Breathing Support Through the Nose
    + 5 other changes: index terms, verification date, description, conditions and design details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07681934
Responsible party
Hediye Karakoç (Associate Professor, KTO Karatay University) — Principal investigator
First posted
Jul 2, 2026
Start date
Jun 28, 2024
Primary completion
Apr 30, 2026
Completion
Aug 30, 2026
Last update
Nov 13, 2026

Study contacts

Hediye Karakoç
principal investigator · KTO Karatay Üniversitesi

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion